Hypothalamic orexin-A neurons are involved in the response of the brain stress system to morphine withdrawal

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Laorden, M Luisa ^a,b   Ferenczi, Szilamér ^c   Pintér Kübler, Bernadett ^c   González Martín, Laura L ^a,b   Lasheras, M Carmen ^a,b   Kovács, Krisztina J ^c   Milanés, M Victoria ^a,b   Núñez, Cristina ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b Instituto Murciano de Investigacion Biosanitaria IMIB   (Spain)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; CORTICOSTERONE; MESSENGER RNA; MORPHINE; NALOXONE; OPIATE; OREXIN A; PLACEBO; PROTEIN C FOS; G PROTEIN COUPLED RECEPTOR; NARCOTIC AGENT; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; SIGNAL PEPTIDE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR STRESS SIGNAL; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LATERAL HYPOTHALAMUS; MALE; MENTAL STRESS; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; OXA GENE; PARAVENTRICULAR THALAMIC NUCLEUS; PROTEIN EXPRESSION; RAT; STRIA TERMINALIS; WITHDRAWAL SYNDROME; ANIMAL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MORPHINE ADDICTION; PATHOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

AMYGDALA; ANIMALS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; NEURONS; NEUROPEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84860711189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036871     Document Type: Article

References (42)

1. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
2. de Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, et al. (1998) The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. PNAS 95: 322-327.
3. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin Knockout Mice: Molecular Genetics of Sleep Regulation. Cell 98: 437-451.
4. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, et al. (1998) Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems. The Journal of Neuroscience 18: 9996-10015.
5. Baldo BA, Daniel RA, Berridge CW, Kelley AE, (2003) Overlapping distributions of orexin/hypocretin- and dopamine-β-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464: 220-237.
6. Carter ME, Borg JS, de Lecea L, (2009) The brain hypocretins and their receptors: mediators of allostatic arousal. Current Opinion in Pharmacology 9: 39-45.
7. Owens MJ, Nemeroff CB, (1991) Physiology and Pharmacology of corticotropin releasing factor. Pharmacol Rev 43: 425-473.
8. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G, (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
9. Navarro-Zaragoza J, Núñez C, Ruiz-Medina J, Laorden ML, Valverde O, et al. (2011) CRF(2) mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. Br J Pharmacol 162: 851-862.
10. Koob GF, Le Moal M, (2008) Addiction and the brain antireward system. Ann Rev Physiol 59: 29-53.
11. Zhou Y, Proudnikov D, Yuferov V, Kreek MJ, (2010) Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. Brain Res 1314: 235-252.
12. Samson WK, Taylor MM, Follwell M, Ferguson AV, (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regulatory Peptides 104: 97-103.
13. Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, et al. (2000) Centrally administered orexin/hypocretin activates HPA axis in rats. NeuroReport 11.
14. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, et al. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23: 3106-3111.
15. Sharf R, Sarhan M, DiLeone RJ, (2008) Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 64: 175-183.
16. Azizi H, Mirnajafi-Zadeh J, Rohampour K, Semnanian S, (2010) Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats. Neurosci Lett 482: 255-259.
17. Harris GC, Aston-Jones G, (2006) Arousal and reward: a dichotomy in orexin function. Trends in Neurosciences 29: 571-577.
18. Chang H, Saito T, Ohiwa N, Tateoka M, Deocaris CC, et al. (2007) Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats. Neuroscience Research 57: 462-466.
19. Núñez C, Foldes A, Laorden ML, Milanes MV, Kovács KJ, (2007) Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem 101: 1060-1071.
20. Núñez C, Földes A, Pérez-Flores D, García-Borrón JC, Laorden ML, et al. (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150: 3118-3127.
21. Olive MF, Koenig HN, Nannini MA, Hodge CW, (2002) Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacology Biochemistry and Behavior 72: 213-220.
22. Laorden ML, Fuertes G, González-Cuello A, Milanés MV, (2000) Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of α1- and α2-adrenoceptors. J Pharmacol Exp Ther 293: 578-584.
23. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LHT, Guan XM, (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Letters 438: 71-75.
24. Stinus L, Le Moal M, Koob GF, (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767-773.
25. Aston-Jones G, Delfs JM, Druhan J, Zhu Y, (1999) The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877: 486-498.
26. Katayama S, Shigemi K, Cline MA, Furuse M, (2010) Intracerebroventricular injection of orexin-A stimulates monoamine metabolism but not HPA axis in neonatal chicks. Neurosci Lett 484: 157-161.
27. Kagerer SM, Jöhren O, (2010) Interactions of orexins/hypocretins with adrenocortical functions. Acta Physiologica 198: 361-371.
28. Sawchenko PE, Swanson LW, (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 4: 275-325.
29. Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, et al. (2006) Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 142: 999-1004.
30. Sakamoto F, Yamada S, Ueta Y, (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regulatory Peptides 118: 183-191.
31. Harris GC, Aston-Jones G, (2007) Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176: 251-258.
32. Forray MI, Gysling K, (2004) Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Research Reviews 47: 145-160.
33. Li Y, Wang H, Qi K, Chen X, Li S, et al. (2011) Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal. Physiology & Behavior 102: 42-50.
34. Frenois F, Cador M, Caille S, Stinus L, Le Moine C, (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
35. Gold LH, Stinus L, Inturrisi CE, Koob GF, (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellets implantation in the rat. Eur J Pharmacol 253: 45-51.
36. Guitart X, Nestler EJ, (1989) Identification of morphine- and cyclic AMP-regulated phosphoprotein (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine. J Neurosci 9: 4371-4387.
37. Lu L, Liu D, Ceng X, Ma L, (2000) Differential role of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12: 4398-4404.
38. Maldonado R, Blendy JA, Tzavara E, Gass P, Roques BP, et al. (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273: 657-659.
39. Houshyar H, Manalo S, Dallman MF, (2004) Time-Dependent Alterations in mRNA Expression of Brain Neuropeptides Regulating Energy Balance and Hypothalamo-Pituitary-Adrenal Activity after Withdrawal from Intermittent Morphine Treatment. J Neurosci 24: 9414-9424.
40. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, et al. (2000) A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regulatory Peptides 96: 45-51.
41. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B, (2006) The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148: 752-759.
42. Paxinos, G, Watson, C, (2007) The rat brain in stereotaxic coordinates. Amsterdam Academic Press.